(Q40017833)

16 September 2017

The activation of p53 mediated by Epstein-Barr virus latent membrane protein 1 in SV40 large T-antigen transformed cells (English)

1 reference

16 September 2017

0 references

1 reference

Lili Li

1

1 reference

16 September 2017

Shanghui Zhou

2

1 reference

16 September 2017

Xue Chen

3

1 reference

16 September 2017

Lili Guo

4

1 reference

16 September 2017

Zijian Li

5

1 reference

16 September 2017

Duosha Hu

6

1 reference

16 September 2017

Xiangjian Luo

7

1 reference

16 September 2017

Xiaoqian Ma

8

1 reference

16 September 2017

Min Tang

9

1 reference

16 September 2017

Wei Yi

10

1 reference

16 September 2017

Sai Wah Tsao

11

1 reference

16 September 2017

Ya Cao

12

1 reference

16 September 2017

language of work or name

English

0 references

publication date

31 January 2008

1 reference

16 September 2017

1 reference

16 September 2017

582

1 reference

16 September 2017

5

1 reference

16 September 2017

755-762

1 reference

The significance of LMP1 expression in nasopharyngeal carcinoma

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Post-translational modification of p53 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

p53 mutations in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Assessment of p53 expression in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Role of T antigen interactions with p53 in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Identification of p53 unbound to T-antigen in human cells transformed by simian virus 40 T-antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

DNA-damage-inducible p53 activity in SV40-transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Epstein-barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Modulation of p53 transcription regulatory activity and post-translational modification by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2008.01.031

10.1016/J.FEBSLET.2008.01.031

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference